» Articles » PMID: 39093339

Descriptive Epidemiology of 399 Histologically Confirmed Newly Diagnosed Meningeal Solitary Fibrous Tumours and Haemangiopericytomas in France: 2006-2015

Abstract

Purpose: Meningeal solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) are uncommon tumours that have been merged into a single entity in the last 2021 WHO Classification of Tumors of the Central Nervous System. To describe the epidemiology of SFT/HPC operated in France and, to assess their incidence.

Methods: We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed SFT/HPC between 2006 and 2015.

Results: Our study included 399 SFT/HPC patients, operated in France between 2006 and 2015, in one of the 46 participating neurosurgical centres. The incidence reached 0.062, CI[0.056-0.068] for 100,000 person-years. SFT accounted for 35.8% and, HPC for 64.2%. The ratio of SFT/HPC over meningioma operated during the same period was 0.013. SFT/HPC are about equally distributed in women and men (55.9% vs. 44.1%). For the whole population, mean age at surgery was 53.9 (SD ± 15.8) years. The incidence of SFT/HPC surgery increases with the age and, is maximal for the 50-55 years category. Benign SFT/HPC accounted for 65.16%, SFT/HPC of uncertain behaviour for 11.53% and malignant ones for 23.31%. The number of resection progresses as the histopathological behaviour became more aggressive. 6.7% of the patients with a benign SFT/HPC had a second surgery vs.16.6% in case of uncertain behaviour and, 28.4% for malignant SFT/HPC patients.

Conclusion: Meningeal SFT and HPC are rare CNS mesenchymal tumours which both share common epidemiological characteristics, asserting their merging under a common entity. SFT/HPC incidence is less that one case for 1 billion per year and, for around 100 meningiomas-like tumours removed, one SFT/HPC may be diagnosed. SFT/HPC are equally distributed in women and men and, are mainly diagnosed around 50-55 years. The more aggressive the tumour, the higher the probability of recurrence.

Citing Articles

An Invasive Solitary Fibrous Tumor/Hemangiopericytoma Originating From the Falx: A Case Report.

Baskurt O, Seker S, Avci I Cureus. 2025; 16(12):e75850.

PMID: 39822408 PMC: 11736511. DOI: 10.7759/cureus.75850.

References
1.
Bauchet L, Rigau V, Mathieu-Daude H, Figarella-Branger D, Hugues D, Palusseau L . French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol. 2007; 84(2):189-99. DOI: 10.1007/s11060-007-9356-9. View

2.
Berghoff A, Kresl P, Bienkowski M, Koelsche C, Rajky U, Hainfellner J . Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma. Clin Neuropathol. 2017; 36 (2017)(2):56-59. DOI: 10.5414/NP300993. View

3.
Bisceglia M, Galliani C, Giannatempo G, Lauriola W, Bianco M, DAngelo V . Solitary fibrous tumor of the central nervous system: a 15-year literature survey of 220 cases (August 1996-July 2011). Adv Anat Pathol. 2011; 18(5):356-92. DOI: 10.1097/PAP.0b013e318229c004. View

4.
Bouvier C, Metellus P, Maues de Paula A, Vasiljevic A, Jouvet A, Guyotat J . Solitary fibrous tumors and hemangiopericytomas of the meninges: overlapping pathological features and common prognostic factors suggest the same spectrum of tumors. Brain Pathol. 2011; 22(4):511-21. PMC: 8057625. DOI: 10.1111/j.1750-3639.2011.00552.x. View

5.
Champeaux C, Weller J, Katsahian S . Epidemiology of meningiomas. A nationwide study of surgically treated tumours on French medico-administrative data. Cancer Epidemiol. 2018; 58:63-70. DOI: 10.1016/j.canep.2018.11.004. View